BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 36434946)

  • 21. Guideline-concordant treatment is associated with improved survival among women with non-endometrioid endometrial cancer.
    Dholakia J; Llamocca E; Quick A; Salani R; Felix AS
    Gynecol Oncol; 2020 Jun; 157(3):716-722. PubMed ID: 32217002
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differences in breast cancer stage at diagnosis and cancer-specific survival by race and ethnicity in the United States.
    Iqbal J; Ginsburg O; Rochon PA; Sun P; Narod SA
    JAMA; 2015 Jan; 313(2):165-73. PubMed ID: 25585328
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Disparities in 1-Year-Mortality in Infants With Cyanotic Congenital Heart Disease: Insights From Contemporary National Data.
    Steurer MA; McCulloch C; Santana S; Collins JW; Branche T; Costello JM; Peyvandi S
    Circ Cardiovasc Qual Outcomes; 2023 Jul; 16(7):e009981. PubMed ID: 37463254
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Racial/ethnic differences in the utilization of chemotherapy among stage I-III breast cancer patients, stratified by subtype: Findings from ten National Program of Cancer Registries states.
    Zhang L; King J; Wu XC; Hsieh MC; Chen VW; Yu Q; Fontham E; Loch M; Pollack LA; Ferguson T
    Cancer Epidemiol; 2019 Feb; 58():1-7. PubMed ID: 30415099
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Variation in type II endometrial cancer risk by Hispanic subpopulation: An exploratory analysis.
    Schlumbrecht M; Baeker Bispo JA; Balise RR; Huang M; Slomovitz B; Kobetz E
    Gynecol Oncol; 2017 Nov; 147(2):329-333. PubMed ID: 28888539
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduction in Breast Cancer Death With Adjuvant Chemotherapy Among US Women According to Race, Ethnicity, and the 21-Gene Recurrence Score.
    Huang HC; Calip GS; Weiss J; Simons Y; Gadi VK; Danciu OC; Rauscher GH; Hoskins KF
    J Natl Compr Canc Netw; 2024 Jan; 22(1D):e237077. PubMed ID: 38190799
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Guideline-adherent treatment, sociodemographic disparities, and cause-specific survival for endometrial carcinomas.
    Rodriguez VE; LeBrón AMW; Chang J; Bristow RE
    Cancer; 2021 Jul; 127(14):2423-2431. PubMed ID: 33721357
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Residential racial segregation and mortality among black, white, and Hispanic urban breast cancer patients in Texas, 1995 to 2009.
    Pruitt SL; Lee SJ; Tiro JA; Xuan L; Ruiz JM; Inrig S
    Cancer; 2015 Jun; 121(11):1845-55. PubMed ID: 25678448
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Racial/ethnic disparities in sleep-disordered breathing during pregnancy in the nuMoM2b study.
    Lucchini M; Rayport Y; Valeri L; Jelic S; St-Onge MP; O'Brien LM; Alcantara C
    Obesity (Silver Spring); 2023 Apr; 31(4):923-933. PubMed ID: 36863765
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Racial/ethnic differences in breast cancer survival by inflammatory status and hormonal receptor status: an analysis of the Surveillance, Epidemiology, and End Results data.
    Schinkel JK; Zahm SH; Jatoi I; McGlynn KA; Gallagher C; Schairer C; Shriver CD; Zhu K
    Cancer Causes Control; 2014 Aug; 25(8):959-68. PubMed ID: 24839049
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of race and ethnicity in the State Children's Health Insurance Program (SCHIP) in four states: are there baseline disparities, and what do they mean for SCHIP?
    Shone LP; Dick AW; Brach C; Kimminau KS; LaClair BJ; Shenkman EA; Col JF; Schaffer VA; Mulvihill F; Szilagyi PG; Klein JD; VanLandeghem K; Bronstein J
    Pediatrics; 2003 Dec; 112(6 Pt 2):e521. PubMed ID: 14654674
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Racial Differences in Time to Breast Cancer Surgery and Overall Survival in the US Military Health System.
    Eaglehouse YL; Georg MW; Shriver CD; Zhu K
    JAMA Surg; 2019 Mar; 154(3):e185113. PubMed ID: 30673075
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patient Characteristics at Prostate Cancer Diagnosis in Different Races at an Academic Center Serving a Diverse Population.
    Suresh T; Sharma J; Goel S; Kovac E; Gao Q; Gartrell B
    Clin Genitourin Cancer; 2019 Apr; 17(2):139-144. PubMed ID: 30655076
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Who, where, when: Colorectal cancer disparities by race and ethnicity, subsite, and stage.
    Primm KM; Malabay AJ; Curry T; Chang S
    Cancer Med; 2023 Jul; 12(13):14767-14780. PubMed ID: 37212502
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disparities in Infant Mortality by Race Among Hispanic and Non-Hispanic Infants.
    Rice WS; Goldfarb SS; Brisendine AE; Burrows S; Wingate MS
    Matern Child Health J; 2017 Jul; 21(7):1581-1588. PubMed ID: 28197819
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The ongoing racial disparities in melanoma: An analysis of the Surveillance, Epidemiology, and End Results database (1975-2016).
    Qian Y; Johannet P; Sawyers A; Yu J; Osman I; Zhong J
    J Am Acad Dermatol; 2021 Jun; 84(6):1585-1593. PubMed ID: 32861710
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exploring the complexity and spectrum of racial/ethnic disparities in colon cancer management.
    Greenberg AL; Brand NR; Zambeli-Ljepović A; Barnes KE; Chiou SH; Rhoads KF; Adam MA; Sarin A
    Int J Equity Health; 2023 Apr; 22(1):68. PubMed ID: 37060065
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Racial and ethnic disparities in extremes of fetal growth after gestational diabetes mellitus.
    Xiang AH; Black MH; Li BH; Martinez MP; Sacks DA; Lawrence JM; Buchanan TA; Jacobsen SJ
    Diabetologia; 2015 Feb; 58(2):272-81. PubMed ID: 25341460
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Racial and Ethnic Disparities in Survival Among People With Second Primary Cancer in the US.
    Sung H; Nisotel L; Sedeta E; Islami F; Jemal A
    JAMA Netw Open; 2023 Aug; 6(8):e2327429. PubMed ID: 37540510
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Racial and ethnic disparities over time in the treatment and mortality of women with gynecological malignancies.
    Rauh-Hain JA; Melamed A; Schaps D; Bregar AJ; Spencer R; Schorge JO; Rice LW; Del Carmen MG
    Gynecol Oncol; 2018 Apr; 149(1):4-11. PubMed ID: 29605048
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.